{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:30:03Z","timestamp":1791178203553,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta neurochir"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1007\/bf01411434","type":"journal-article","created":{"date-parts":[[2005,4,3]],"date-time":"2005-04-03T06:28:56Z","timestamp":1112509736000},"page":"44-50","source":"Crossref","is-referenced-by-count":25,"title":["Tenascin distribution in human brain tumours"],"prefix":"10.1007","volume":"136","author":[{"given":"P.","family":"Castellani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dorcaratto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Siri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Zardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. L.","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-5793(93)80479-E","volume":"332","author":"E Balza","year":"1993","unstructured":"Balza E, Siri A, Ponassi M, Caocci F, Linnala A, Virtanen I, Zardi L (1993) Production and characterization of monoclonal antibodies specific for different epitopes of human tenascin. FEBS 332: 39?43","journal-title":"FEBS"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ijc.2910520504","volume":"52","author":"L Borsi","year":"1992","unstructured":"Borsi L, Carnemolla B, Nicole G, Spina B, Tanara G, Zardi L (1992) Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J Cancer 52: 688?692","journal-title":"Int J Cancer"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/15419069409097262","volume":"1","author":"L Borsi","year":"1994","unstructured":"Borsi L, Balza E, Castellani P, Carnemolla B, Ponassi M, Querz\u00e8 G, Zardi L (1994) Cell-cycle dependent alternative splicing of the tenascin primary transcript. Cell Adhesion Communication 1: 307?317","journal-title":"Cell Adhesion Communication"},{"key":"CR4","first-page":"2796","volume":"43","author":"MA Bourdon","year":"1983","unstructured":"Bourdon MA, Wikstrand CJ, Furthmayr H, Matthews TJ, Bigner DD (1983) Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 43: 2796?2805","journal-title":"Cancer Res"},{"key":"CR5","first-page":"133","volume":"4","author":"MA Bourdon","year":"1984","unstructured":"Bourdon MA, Coleman RE, Blasberg RG, Groothuis DR, Bigner DD (1984) Monoclonal antibody localization in subcutaneous and intracranial human glioma xenograft: paired-label and imaging analysis. Anticancer Res 4: 133?140","journal-title":"Anticancer Res"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3171\/jns.1986.64.2.0257","volume":"64","author":"DE Bullard","year":"1986","unstructured":"Bullard DE, Adams CJ, Coleman RE, Bigner DD (1986) In vivo imaging of intracranial human glioma xenograft comparing specific with non specific radiolabeled monoclonal antibodies. J Neurosurg 64: 257?262","journal-title":"J Neurosurg"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1432-1033.1992.tb16813.x","volume":"205","author":"B Carnemolla","year":"1992","unstructured":"Carnemolla B, Borsi L, Bannikov G, Troyanovsky S, Zardi L (1992) Comparison of human tenascin expression in normal, SV-40 transformed and tumour derived cell lines. Eur J Biochem 205: 561?567","journal-title":"Eur J Biochem"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1096\/fasebj.4.9.1693347","volume":"4","author":"R Chiquet-Ehrismann","year":"1990","unstructured":"Chiquet-Ehrismann R (1990) What distinguishes tenascin from fibronectin? FASEB J4: 2598?2604","journal-title":"FASEB"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/0955-0674(91)90053-2","volume":"3","author":"R Chiquet-Ehrismann","year":"1991","unstructured":"Chiquet-Ehrismann R (1991) Anti-adhesive molecules of the extracellular matrix. Curr Opin Cell Biol 3: 800?884","journal-title":"Curr Opin Cell Biol"},{"key":"CR10","first-page":"427","volume":"138","author":"CM Choung","year":"1991","unstructured":"Choung CM, Chen HM (1991) Enhanced expression of neural cell adhesion molecules and tenascin (cytotactin) during wound healing. Am J Pathol 138: 427?440","journal-title":"Am J Pathol"},{"key":"CR11","first-page":"5701","volume":"48","author":"EV Colapinto","year":"1988","unstructured":"Colapinto EV, Humphrey PA, Zalutsky MR, Groothuis DR, Friedman HS, De Tribolet N, Carrel S, Bigner DD (1988) Comparative localization of murine monoclonal antibody MEL-14 (ab')2 fragment and whole IgG2a in human glioma xenografts. Cancer Res 48: 5701?5707","journal-title":"Cancer Res"},{"key":"CR12","unstructured":"De Santi MS, Acampora S, Lastoria S, Castelli L, Vergara E, Valentino V, Ambrosio A (1993) Diagnosis and treatment of brain hemisferic gliomas. Proc EANS Meet. ?Multimodality treatment for intracranial tumours?, Rome, p 4"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0968-0004(92)90383-K","volume":"17","author":"GM Edelman","year":"1992","unstructured":"Edelman GM, Jones FS (1992) Cytotactin ? a morphoregulatory molecule and a target for regulation by homeobox gene products. Trends Biochem Sci 17: 228?232","journal-title":"Trends Biochem Sci"},{"key":"CR14","first-page":"71","volume":"33","author":"P Ekblom","year":"1989","unstructured":"Ekblom P, Aufderheide E (1989) Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions. Int J Dev Biol 33: 71?79","journal-title":"Int J Dev Biol"},{"key":"CR15","first-page":"3183","volume":"46","author":"AA Epenetos","year":"1986","unstructured":"Epenetos AA, Snook D, Darbin H, Johnson PM, Taylor-Papadimitros J (1986) Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms. Cancer Res 46: 3183?3191","journal-title":"Cancer Res"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev.cb.05.110189.000443","volume":"5","author":"HP Erickson","year":"1989","unstructured":"Erickson HP, Bourdon MA (1989) Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Ann Rev Cell Biol 5: 71?92","journal-title":"Ann Rev Cell Biol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1083\/jcb.108.5.1873","volume":"108","author":"CL Gatchalian","year":"1989","unstructured":"Gatchalian CL, Schachner M, Sanes JR (1989) Fibroblasts that proliferative near denervated synaptic sites in skeletal muscle synthesize the adhesive molecules (J1), N-CAM, firbonectin and a heparan sulfate proteoglycan. J Cell Biol 108: 1873?1890","journal-title":"J Cell Biol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF00230486","volume":"85","author":"M Higuchi","year":"1993","unstructured":"Higuchi M, Ohnishi T, Arita N, Hiraga S, Hayakawa T (1993) Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol 85: 481?487","journal-title":"Acta Neuropathol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/0046-8177(91)90285-W","volume":"22","author":"GK Koukoulis","year":"1991","unstructured":"Koukoulis GK, Gould VE, Bhattacharyya A, Gould JE, Howeedy AA, Virtanen I (1991) Tenascin in normal, reactive, hyperplastic and neoplastic tissues: biologic and pathologic implications. Hum Path 22: 636?643","journal-title":"Hum Path"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1073\/pnas.89.7.2634","volume":"89","author":"EQ Laywell","year":"1992","unstructured":"Laywell EQ, Domes U, Bartsch U, Faissner A, Schachner M, Steindler DA (1992) Enhanced expression of the developmentally regulated extracellular matrix molecule tenascin following adult brain injury. Proc Natl Acad Sci USA 89: 2634?2638","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR21","first-page":"559","volume":"48","author":"YS Lee","year":"1988","unstructured":"Lee YS, Bullard DE, Zalutsky MR, Coleman RE, Wikstrand CJ, Friedman HS, Colapinto EV, Bigner DD (1988) Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131-I radiolabeled murine monoclonal antibody in a human glioma xenograft model. Cancer Res 48: 559?566","journal-title":"Cancer Res"},{"key":"CR22","first-page":"2904","volume":"48","author":"YS Lee","year":"1988","unstructured":"Lee YS, Bullard DE, Humphrey PA, Colapinto DV, Friedman HS, Zalutsky MR, Coleman RE, Bigner DD (1988) Treatment of intracranial human glioma xenograft with I-131 labeled anti-tenascin monoclonal antibody 81C6. Cancer Res 48: 2904?2910","journal-title":"Cancer Res"},{"key":"CR23","first-page":"117","volume":"2","author":"A Leprini","year":"1994","unstructured":"Leprini A, Querz\u00e9 G, Zardi L (1994) Tenascin isoforms: possible targets for diagnosis and therapy of cancer and mechanisms regulating their expression. Perspectives on Developmental Neurobiology 2: 117?123","journal-title":"Perspectives on Developmental Neurobiology"},{"key":"CR24","first-page":"7437","volume":"86","author":"EJ Mackie","year":"1987","unstructured":"Mackie EJ, Chiquet-Ehrismann R, Pearson CA, Inaguma Y, Taya K, Kawarada Y, Sakakura T (1987) Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci USA 86: 7437?7441","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1083\/jcb.107.6.2757","volume":"107","author":"EJ Mackie","year":"1988","unstructured":"Mackie EJ, Halfter W, Liverani D (1988) Induction of tenascin in healing wounds. J Cell Biol 107: 2757?2767","journal-title":"J Cell Biol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02228895","volume":"3","author":"RD McComb","year":"1985","unstructured":"McComb RD, Bigner DD (1985) Immunolocalization of monoclonal antibody defined extracellular matrix antigens in human brain tumors. J Neurooncol 3: 181?186","journal-title":"J Neurooncol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00005072-199005000-00254","volume":"49","author":"RD McComb","year":"1990","unstructured":"McComb RD, Miller KA (1990) Developmental and reactive expression of tenascin (TN) in the human cerebellum. J Neuropathol Exp Neurol 49: 344","journal-title":"J Neuropathol Exp Neurol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/ijc.2910470603","volume":"48","author":"PG Natali","year":"1991","unstructured":"Natali PG, Nicotra MR, Bigotti A, Botti C, Castellani P, Risso AM, Zardi L (1991) Comparative analysis of the expression of the extracellular matrix protein ?tenascin? in normal human fetal, adult and tumor tissues. Int J Cancer 48: 811?816","journal-title":"Int J Cancer"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0922-3371(90)90056-3","volume":"32","author":"G Nicol\u00f2","year":"1990","unstructured":"Nicol\u00f2 G, Salvi S, Oliveri G, Borsi L, Castellani P, Zardi L (1990) Expression of tenascin and of the ED-B containing oncofetal fibronectin isoform in human cancer. Cell Diff Develop 32: 401?408","journal-title":"Cell Diff Develop"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/BF00947966","volume":"21","author":"G Paganelli","year":"1994","unstructured":"Paganelli G, Magnani F, Zito F, Lucignani G, Sudati F, Truci G, Motti E, Terreni M, Polio B, Giovanelli M, Canal N, Scotti G, Comi G, Koch P, Maecke HR, Fazio F (1994) Pre-targeting immunodetection in glioma patient: tumor localization and SPECT imaging of [Tc-99m]PnAO biotin. J Nucl Med 21: 314?321","journal-title":"J Nucl Med"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910510102","volume":"51","author":"P Riva","year":"1992","unstructured":"Riva P, Arista A, Sturiale C, Moscatelli G, Tison V, Mariani M, Seccamani E, Lazzari S, Fagioli L, Franceschi G, Sarti G, Riva N, Natali PG, Zardi L, Scassellati GA (1992) Treatment of intracranial human glioblastoma by direct intratumoral administration of 1311-labelled anti-tenascin monoclonal antibody BC-2. Int J Cancer 51: 1?7","journal-title":"Int J Cancer"},{"issue":"Suppl 3","key":"CR32","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/1097-0142(19940201)73:3+<1076::AID-CNCR2820731347>3.0.CO;2-Z","volume":"73","author":"P Riva","year":"1994","unstructured":"Riva P, Arista A, Sturiale C, Tison V, Fratterelli M, Lazzari S, Moscatelli G, Fransceschi G, Spinelli A, Sarti G, Casi M, Riva N (1994) Radioimmunotherapy of CNS malignant gliomas by direct intralesional injection of specific 131 I radiolabelled monoclonal antibodies. Cancer 73 [Suppl 3]: 1076?1082","journal-title":"Cancer"},{"key":"CR33","first-page":"1143","volume":"139","author":"J Schalkwijk","year":"1991","unstructured":"Schalkwijk J, Steijlen PM, Van Vlijmen W, Oosterling B, Mackie EJ, Verstraeten AA (1991) Tenascin expression in human dermis is related to epidermal proliferation. Am J Pathol 139: 1143?1150","journal-title":"Am J Pathol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/nar\/19.3.525","volume":"19","author":"A Siri","year":"1991","unstructured":"Siri A, Carnemolla B, Saginati M, Leprini A, Casari G, Baralle F, Zardi L (1991) Human tenascin primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies. Nucleic Acid Res 19: 525?531","journal-title":"Nucleic Acid Res"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1242\/jcs.104.1.69","volume":"104","author":"RP Tucker","year":"1993","unstructured":"Tucker RP, Hammerback JA, Jenrath DA, Mackie EJ, Xu J (1993) Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF. J Cell Sci 104: 69?73","journal-title":"J Cell Sci"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-5728(92)90029-K","volume":"36","author":"JB Ventimiglia","year":"1992","unstructured":"Ventimiglia JB, Wikstrand CJ, Ostrowski LE, Bourdon MA, Lightner VA, Bigner DD (1992) Tenascin expression in human glioma cell lines and normal tissues. J Neuroimmunol 36: 41?55","journal-title":"J Neuroimmunol"},{"key":"CR37","first-page":"2807","volume":"49","author":"MR Zalutsky","year":"1989","unstructured":"Zalutsky MR, Moseley RP, Coakham HB, Coleman RE, Bigner DD (1989) Pharmacokinetics and tumor localization of131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies. Cancer Res 49: 2807?2813","journal-title":"Cancer Res"},{"key":"CR38","first-page":"4105","volume":"50","author":"MR Zalutsky","year":"1990","unstructured":"Zalutsky MR, Moslley RP, Benjamin JC, Colapinto EV, Fuller GN, Coakham HP, Bigner DD (1990) Monoclonal antibody and F8 ab')2 fragment delivery to tumour in patients with glioma: comparison of intracarotid and intravenous administration. Cancer Res 50: 4105?4110","journal-title":"Cancer Res"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01411434.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01411434\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01411434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T22:44:19Z","timestamp":1625697859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01411434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["BF01411434"],"URL":"https:\/\/doi.org\/10.1007\/bf01411434","relation":{},"ISSN":["0001-6268","0942-0940"],"issn-type":[{"value":"0001-6268","type":"print"},{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}